Correction: MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples

• Gonçalo Outeiro-Pinho,
• Daniela Barros-Silva,
• Elena Aznar,
• Ana-Isabel Sousa,
• Márcia Vieira-Coimbra,
• Jorge Oliveira,
• Céline S. Gonçalves,
• Bruno M. Costa,
• Kerstin Junker,
• Rui Henrique,
• Carmen Jerónimo

Affiliations

Gonçalo Outeiro-Pinho

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Daniela Barros-Silva

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Elena Aznar

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Ana-Isabel Sousa

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Márcia Vieira-Coimbra

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Jorge Oliveira

Department of Urology, Portuguese Oncology Institute of Porto (IPO Porto)

Céline S. Gonçalves

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho

Bruno M. Costa

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho

Kerstin Junker

Department of Urology and Pediatric Urology, Saarland University

Rui Henrique

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)

Carmen Jerónimo

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)